Empowering Omics-based Precision Medicine

with TAIGenomics Solutions

Precision Medicine

Empowering Omics-based

with TAIGenomics Solutions

Multi-omics Analyses Cloud

Multi-omics Analyses Cloud

Explore TAIGenomics

TAIGenomics offers an AI-driven omics data platform that enables healthcare providers and medical researchers to find the next clinical action plan. Our solutions can seamlessly analyze and interpret the experiment or clinical data across different disease areas, including heredity common disease risk, rare disease, and oncology. Partnering with TAIGenomics now to achieve your blueprint about the future of precision medicine.

Efficient omics bioinformatics tool set up & validation

Connecting data and information with AI

Flexible analytics architecture

Perform a patient’s absolute risk of common chronic disease.

Our Advantages

A scalable analytics platform on the cloud

Automated multi-omics analyses workflows

Ready to use graphical user interface

Copyright © 2021 TAIGenomics. All Rights Reserved.

1. Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases. FDA, Jul. 2016

2. Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics. FDA, Jul. 2016

3. Clinical laboratory standards for next-generation sequencing. ACMG, Sep. 2013.

4. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. ACMG, Mar. 2015.

5. Good laboratory practice for clinical next-generation sequencing informatics pipelines. CDC, Jul. 2015.

6. Guidelines for Validation of Next-Generation Sequencing Based Oncology Panels. AMP/CAP, May. 2017.

7. "Next Generation" Sequencing (NGS) guidelines for somatic genetic variant detection. NYSDOH, Mar. 2015.

8. Guidelines for diagnostic next-generation sequencing. EuroGentest, Oct. 2015.

9. Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice. CDC, Nov. 2012.

Contact us